Theranos

According to the Ninth Circuit's synthesis of the trial record, Theranos developed roughly 300 small-sample assays during Elizabeth Holmes's tenure, but only 12 of those assays were ever run on the company's own Edison analyzer; other general-chemistry tests were run on third-party machines instead. Collection method, analyzer identity, and assay identity are therefore distinct attributes of any given test, and this record addresses only the Edison-assay count the trial-record synthesis states — it does not, on this source alone, resolve which analyzer ran any specific test outside that count.

TH-S01, retained here as a captured copy, is the SEC's 2018 civil enforcement complaint against Theranos and Elizabeth Holmes. A civil complaint records the agency's allegations at the time of filing; it is not itself an adjudicated or admitted finding. This record does not restate the complaint's specific allegations as established fact — only that the complaint exists, was filed by the SEC in 2018, and names Theranos and Holmes.

TH-S09, retained here as a captured copy, is the Ninth Circuit's order and amended opinion (December 2025) in the consolidated criminal appeals of Elizabeth Holmes and Ramesh Balwani. An appellate opinion is a distinct adjudicative layer from the trial verdicts and sentencing decisions it reviews. This record presents the captured opinion and its provenance chain; it does not restate the opinion's disposition of those appeals as an established outcome — the underlying criminal-trial outcomes are addressed separately, and are not asserted here.